Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1440, 2004-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cancer vaccination with telomerase peptide GV1001
Expert Opinion on Investigational Drugs, Vol. 18, Iss. 5, 2009-05 ,pp. :
Access to resources
Recommend
Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients
By Kawano Kouichiro Tsuda Naotake Matsueda Satoko Sasada Tetsuro Watanabe Noriko Ushijima Kimio Yamaguchi Tomohiko Yokomine Masato Itoh Kyogo Yamada Akira Kamura Toshiharu
Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 3, 2014-06 ,pp. :
Prospects for Vaccination in Prostate Cancer
By Perry M.J.A. Hrouda D. Dalgleish A.G.
Drugs & Aging, Vol. 16, Iss. 5, 2000-05 ,pp. :
Biosynthesis of Peptide Hormones Derived from Precursor Sequences
Current Medicinal Chemistry, Vol. 11, Iss. 20, 2004-10 ,pp. :